INmune Bio provides update on Alzheimer's candidate XPro
https://seekingalpha.com/news/4096265-inmune-bio-provides-update-alzheimers-candidate-xpro?source=feed_sector_healthcare
Apr 30, 2024 - INmune Bio's experimental Alzheimer's treatment XPro shows promising results in stabilizing cognitive states of patients in compassionate use program. Read more here.
0
Annovis Bio: Alzheimer's Phase 2/3 Topline Readout Puts Future For Buntanetap Into Question
https://seekingalpha.com/article/4688345-annovis-bio-alzheimer-phase-2-3-topline-readout-puts-buntanetap-future-into-question?source=feed_all_articles
May 01, 2024 - Annovis faces financial challenges and may see a significant decline in stock prices. Find out why ANVS stock is a Sell.
0
Pages: 1
Page 1